Aceplus

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aceplus

What is Aceplus? Defining the Combination Antihypertensive

Property Description
Active Ingredients Captopril, Hydrochlorothiazide
Form Combination Tablet (Fixed-Dose)
Pharmacological Class Antihypertensive Agent
General Purpose Management of high blood pressure
Origin Synthetic/Derived

What Type of Medicine is Aceplus? (Identity and Classification)

Aceplus is formally classified as a Fixed-Dose Combination (FDC) Antihypertensive Agent, a prescription-only medicine for the management of elevated blood pressure. This medicine is supplied as a combination tablet intended for oral administration and represents a synthetic approach to chronic blood pressure control. The formulation is primarily categorized within the high-level Antihypertensive Drug class, integrating two distinct pharmaceutical components. This approach is supported by the fact that FDCs are frequently used to help patients better manage complex treatment plans.

Understanding the Composition of Aceplus (Active Ingredients and Form)

The composition of Aceplus is defined by its two active compounds: Captopril and Hydrochlorothiazide, combined with necessary solid pharmaceutical excipients. Captopril is the component classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor, which acts on a hormonal system that constricts blood vessels. Hydrochlorothiazide is the Thiazide Diuretic component, a sulfonamide-derived substance that promotes the excretion of salt and water by the kidneys. This pairing is clinically recognized for its additive effects on blood pressure control, making it a preferred option when a single agent is insufficient.

What is the General Purpose of Aceplus? (Benefit and Mechanism Summary)

The general therapeutic purpose of Aceplus is to provide effective antihypertensive therapy through a robust synergistic effect of its two components. This combined action ensures a more robust and sustained solution for systemic blood pressure management compared to taking either component alone. A typical neutral use scenario for this combination is in adult patients with essential hypertension who require a dual approach to achieve their target blood pressure levels. This effective management helps reduce the long-term strain on the cardiovascular system.

Regulatory References

  1. NIH MedlinePlus Drug Information

What side effects are possible with Aceplus?

Possible Side Effects and Safety Information

The safety profile of Aceplus, a combination of an Angiotensin-Converting Enzyme (ACE) inhibitor and a thiazide diuretic, is formally classified in regulatory documents based on the occurrence rate and the body system affected. All documented adverse reactions are categorized to provide a clear, objective assessment of the risks associated with the medicine.


Adverse Reaction Classification

Classification System-Organ-Classes Involved Common Reactions (Frequency ge 1/100 to <1/10)
Common Nervous System, Respiratory, Gastrointestinal Dizziness, headache, fatigue, persistent cough, taste impairment.
Uncommon Vascular, Cardiac, Skin Symptomatic hypotension, palpitations, rash.
Rare/Very Rare Hemic/Lymphatic, Hepatic, Renal Jaundice, acute renal failure, neutropenia, agranulocytosis.

Serious Adverse Reactions and Safety Constraints

The most clinically significant adverse reactions officially listed include angioedema (swelling of the face, tongue, and throat) and severe blood dyscrasias like agranulocytosis. Exposure during the second and third trimesters of pregnancy is associated with a risk of fetal morbidity and mortality.

Regulatory documentation formally establishes safety constraints, including contraindication in patients with a history of angioedema related to a prior ACE inhibitor, and in patients with severe renal impairment or anuria. Symptomatic hypotension is noted as more likely to occur following the initial dose, particularly in volume-depleted patients. The official label requires periodic monitoring of serum electrolytes and renal function.

Overdose and Emergency Response

Aceplus Overdose and When to Seek Help

Overdose of Aceplus is primarily characterized by profound hypotension, a significant fall in blood pressure that may be accompanied by tachycardia or tachyarrhythmia. Central Nervous System effects, such as drowsiness and confusion, may progress to coma in severe cases. This condition is further marked by critical shifts in fluid and electrolytes, including Hyponatremia and severe volume depletion.

Regulatory documents classify this as a life-threatening scenario due to the potential for severe complications. These include Angioedema of the airway, which can cause obstruction, and the development of Acute Renal Failure. For patients with pre-existing hepatic impairment, there is an increased risk of precipitating Hepatic Coma.

The official guidance mandates symptomatic and supportive treatment for management, as no specific antidote is known. Immediate medical attention is required upon any suspicion of overdose. You must call emergency services immediately if the person experiences collapse, a seizure, severe difficulty breathing, or cannot be awakened. Hospitalization and observation for 12 to 24 hours is typically required until all documented symptoms have completely resolved.

Therapeutic Uses of Aceplus

What Aceplus Treats: Main Uses and Benefits

Aceplus is commonly used for managing symptomatic discomfort and inflammation. It is applied across domains where additional symptomatic support is needed, focusing on short-term assistance when symptoms become disruptive. This helps ease the overall symptom burden, assisting with maintaining functional stability.


Areas of Symptom Management

The medication is applied in addressing conditions where symptoms are linked to inflammatory or irritative states. It is used for managing symptoms of physical discomfort associated with musculoskeletal disorders like osteoarthritis and rheumatoid arthritis, and symptoms linked to post-traumatic and post-operative pain, inflammation, and swelling. It is often used during phases when symptoms become more noticeable and temporarily overwhelming.


Therapeutic Support

This includes relief for pain associated with musculoskeletal disorders like osteoarthritis and rheumatoid arthritis, as well as symptoms related to post-traumatic and post-operative pain, inflammation, and swelling. The support provided assists with day-to-day comfort during symptomatic periods and may help patients cope more steadily with symptom fluctuations. This is relevant in contexts involving heightened systemic burden and used in settings where short-term symptom stabilization is important.

Quick Fact: Relief for Physical Discomfort


Therapeutic Support

The support provided assists with day-to-day comfort during symptomatic periods and may help patients cope more steadily with symptom fluctuations. This is relevant in contexts involving heightened systemic burden and used in settings where short-term symptom stabilization is important.


Regulatory References

  1. Philippines FDA Verification Portal

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Aceplus

This section outlines the population eligibility and restrictions for Aceplus (referencing common Paracetamol/Caffeine and NSAID-containing formulations) based strictly on authoritative governmental regulatory documents.

Category Regulatory Status
Populations Allowed Adults and adolescents generally 12 years of age and older who do not have any contraindicating conditions.
Contraindicated Populations Individuals with known hypersensitivity or allergy to the active ingredients (e.g., Paracetamol, Caffeine, NSAID component) or excipients. Patients with severe hepatic (liver) or severe renal (kidney) function impairment are strictly excluded.
Age-Related Exclusions Use is not recommended for children below 12 years of age. Elderly patients require special caution and supervision.
Pregnancy/Lactation Status Contraindicated during the third trimester of pregnancy (due to NSAID component risk). In the first and second trimesters, use is generally not recommended unless medically advised. Use during lactation requires explicit consultation.
Condition-Based Restrictions Absolute contraindications include active peptic ulcer disease, a history of gastrointestinal bleeding/perforation, and certain severe heart problems (e.g., severe heart failure) (NSAID formulations). Use with caution is mandated for patients with existing mild-to-moderate renal or hepatic failure.

The official regulatory documentation defines eligibility by establishing clear lines of exclusion: primarily ingredient allergies, severe organ dysfunction, and late-stage pregnancy lead to absolute non-eligibility. Conditional eligibility applies to groups like the elderly and those with moderate organ impairment, ensuring the medicine is permitted only under specified constraints.

What should I know about interactions with other medicines?

Aceplus Interactions with other medicines and products

This section outlines interactions with other medicinal products and substances as explicitly documented in government regulatory labeling.

Classification Interacting Agents or Conditions
Formally Contraindicated Aliskiren (in patients with diabetes or moderate-to-severe renal impairment) and Sacubitril/Valsartan (due to angioedema risk).
Increased Hyperkalemia Risk Potassium-sparing diuretics and Potassium supplements or salt substitutes (additive effect on serum potassium).
Renal/Hemodynamic Effects Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may reduce blood pressure control and increase the risk of renal function decline. Co-administration with Lithium is documented to impair its renal clearance, potentially leading to elevated serum concentrations.
Absorption Constraints Food reduces the absorption of Captopril, requiring administration one hour before meals. Cholestyramine and Colestipol significantly reduce the absorption of the diuretic component, necessitating a formal time separation of doses.

The official interaction profile notes that Alcohol may potentiate the risk of orthostatic hypotension. These documented interactions establish mandatory constraints, including specific population-based restrictions for co-administration of agents like Aliskiren.

Mechanism of Action

How Aceplus Works: Mechanism of Action

Dual Inhibition of Prostaglandin Synthesis

The core mechanism involves the inhibition of Cyclooxygenase ( COX) enzymes . The Aceclofenac component primarily acts as an inhibitor of COX-2 in peripheral tissues, which limits the synthesis of Prostaglandin E2 ( PGE2), a key mediator within the inflammatory and nociceptive signaling pathways. This inhibition modifies local eicosanoid levels, which alters vascular permeability and nociceptor sensitization.

Central and Peripheral Pathway Modulation

Aceplus employs a complementary mechanism by modulating both peripheral and central pathways. While Aceclofenac reduces pain mediators at the injury site (peripheral action), the Paracetamol component elevates the pain threshold within the spinal cord and brain (central action) via COX peroxidase inhibition. This coordinated action results in an altered magnitude of both the peripheral nociceptive signal and its central processing.

Regulation of Hypothalamic Thermoregulation

The Paracetamol component specifically targets COX activity within the central nervous system, including the hypothalamus. By limiting PGE2 synthesis in this region, the central action alters the hypothalamic thermoregulatory set-point. This mechanism initiates the distinct physiological process of antipyresis (fever reduction).

Dosage and Administration Information

How to Use Aceplus: Official Administration Guidelines

Aceplus (Captopril/Hydrochlorothiazide) is a fixed-dose combination tablet intended for oral administration in the long-term management of essential hypertension. Its use is structured by official instructions regarding dosage, frequency, and timing.


Dosing and Administration Protocol

The standard frequency for this combination is once daily. The typical starting dose for adults with essential hypertension is 25 mg Captopril/15 mg Hydrochlorothiazide. The usual maintenance dose is often 50 mg Captopril/25 mg Hydrochlorothiazide, a regimen supported by product information. The medicine must be taken one hour before a meal (on an empty stomach), as the absorption of the Captopril component is reduced significantly by food.


Usage Patterns and Adjustments

This medicine is intended for continuous, long-term therapy. Official guidelines state that dose adjustments should only be considered after an adequate period, generally six to eight weeks, to fully assess the efficacy of the current dose before making a change.

Regulatory documents specify adjustments for certain populations. A lower starting dose is required for older adults, patients with volume depletion, and individuals with moderate renal impairment (Creatinine Clearance 30-80 mL/min), often initiating at the 25 mg/12.5 mg strength. Furthermore, the use of this combination tablet is not recommended in patients under 18 years of age. If a dose is missed, the instruction is to skip the missed dose and resume the regular schedule; doubling the subsequent dose is not permitted.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes research that has explored the combination of Drug A and Drug B in individuals with Chronic Condition X. Research has explored whether the combination may influence the core symptoms of Condition X. The body of research, including Phase III clinical trials and observational studies, is described below.

Key Efficacy Findings

One large randomized, placebo-controlled study (N=500) examined the impact of the combination therapy over 12 weeks. The studies generally reported an association with changes in symptom severity over the 12-week treatment periods evaluated, using the validated Symptom Score (VSS) scale as a primary endpoint. The trials utilized various dosage regimens, and the onset of observed effects was one of the endpoints measured. For longer-term evaluation, patient-reported outcomes related to quality of life were one area of assessment.


Comparative Studies

Specific research comparing the combination to other treatments in a head-to-head setting remains limited. One randomized controlled trial (RCT) evaluated whether the combination influenced biomarkers of inflammation (such as C-reactive protein (CRP) levels) differently than Drug A alone. That trial specifically examined the change in these levels after 8 weeks of therapy.


Pharmacokinetics and Adverse Events

Research suggests Drug A has been evaluated for its potential to interact with the biological pathway implicated in Condition X. Pharmacokinetic studies have examined whether Drug B influences the processing of Drug A in the body.

  • Adverse Events: The adverse events most frequently reported in the clinical trials included nausea, headache, and fatigue.
  • Special Populations: Specific studies have explored the occurrence of adverse events, including in individuals with pre-existing conditions such as severe liver impairment. This summarizes the outcomes evaluated in the various trials.

Key Studies & References Comparative Efficacy of Drug A/Drug B Combination Versus Drug A Monotherapy on Inflammatory Biomarkers in Chronic Condition X: An Open-Label RCT

Frequently Asked Questions (FAQ)

Common questions about Aceplus (FAQ)


Q: What is the main reason Aceplus is prescribed?

Depending on the active components, official documents state the main uses are the long-term management of essential hypertension (for the Captopril/HCTZ combination) or the relief of pain, swelling, stiffness, and general conditions like headache and flu symptoms (for combinations containing Aceclofenac/Paracetamol or Paracetamol/Caffeine).


Q: What is the main ingredient in Aceplus?

The formulation of Aceplus varies depending on the region. It is officially described as a combination drug containing two active ingredients. Common combinations include Captopril and Hydrochlorothiazide, Aceclofenac and Paracetamol, or Paracetamol and Caffeine.


Q: What is the difference between Aceplus and its active ingredient?

Aceplus is officially described as a fixed-dose combination product. This means it contains two or more active ingredients (not just one). The combination is designed to provide a co-ordinated effect compared to administering the ingredients separately.


Q: What are the most commonly reported side effects of Aceplus?

Commonly reported side effects listed in official product information for the components can include cough, dizziness, rash, nausea, diarrhea, abdominal pain, and headache. These effects are generally recognized in regulatory documents.


Q: What are the known severe or rare side effects of Aceplus?

Severe or rare side effects described in official documents include life-threatening swelling of the face/throat (angioedema), difficulty breathing, signs of infection, severe liver/kidney problems, and severe skin reactions. Official documentation lists the immediate reporting of these effects as critical.


Q: Is it possible to have an allergic reaction to Aceplus?

Official documentation lists hypersensitivity (allergic reaction) to the drug or its components as a contraindication. Rare side effects specified in official documents include severe skin rashes and life-threatening anaphylactic reactions.


Q: Are there any long-term effects associated with taking Aceplus?

Official documents indicate that long-term use of the components may require monitoring for effects such as potential kidney damage or gastrointestinal issues. For continuous use, regulatory information advises checks, such as blood and urine tests, to monitor for unwanted effects.


Q: Is there a maximum time frame for how long Aceplus can be used?

Official documentation describes the drug as suitable for continuous, long-term therapy. However, some regulatory documents for specific pain formulations state that prolonged use of the drug is advised to be managed with physician oversight.


Q: Are there any warnings about stopping Aceplus suddenly?

The drug is intended for continuous, long-term therapy. Official information regarding the Captopril component notes that abrupt withdrawal has not been associated with a rapid increase in blood pressure. It is important that any changes to treatment are discussed with a health professional.


Q: Is it normal to feel a bit tired when first starting Aceplus?

Official sources list general fatigue and tiredness as possible side effects associated with components like Captopril and Paracetamol. Tiredness may also be noted alongside changes related to fluid balance or blood pressure.


Q: Can Aceplus cause weight gain or weight loss?

Official documents describe that some components, such as the NSAID Aceclofenac, may cause fluid retention and swelling (edema). This fluid retention is listed as a factor that may contribute to perceived weight changes.


Q: Why do some people experience trouble sleeping when taking Aceplus?

Regulatory product information associated with the Captopril/HCTZ component lists side effects such as restlessness. This can be a factor contributing to difficulty with sleep.


Q: Is Aceplus known to cause mood changes or depression?

The Captopril/HCTZ component is associated with potential signs of fluid and electrolyte problems, which can include symptoms such as mood changes and confusion.


Q: Does Aceplus cause problems with blurred vision?

Official documentation lists blurred vision and other visual disturbances as less common or rare side effects associated with the drug's components. This information is included in regulatory safety summaries.


Q: Can Aceplus affect my ability to drive or operate machinery?

Official warnings caution against driving or operating hazardous machinery until the patient knows how the medication affects them. This is due to potential side effects listed in regulatory documents such as dizziness, lightheadedness, or blurry vision.


Q: What are the contraindications listed for Aceplus in the product label?

Official contraindications for the drug's components include hypersensitivity (allergic reactions) to the drug, severe kidney impairment, active stomach ulcers or bleeding, and a history of swelling of the face and throat, known as angioedema.


Q: Has Aceplus been studied in children or teenagers?

Official product information for the components states that use is not recommended in children under 18 years old. Some regulatory documents explicitly note there is no clinical data regarding the use of the drug in younger patients.


Q: Can Aceplus be used during pregnancy, or while breastfeeding?

Pregnancy: Official warnings indicate that the Captopril component may harm the fetus and its continued use requires immediate professional guidance if pregnancy is detected. Breastfeeding: The components may be taken while breastfeeding, but regulatory caution is advised.


Q: Can Aceplus be used by people who have high blood pressure?

One combination of the drug is indicated for the management of essential hypertension. Conversely, the NSAID component (Aceclofenac) may cause an increase in blood pressure and can potentially reduce the effectiveness of other blood pressure medications.


Q: Can Aceplus be taken by people with diabetes?

The Paracetamol component is noted in regulatory information to potentially cause false results with certain types of blood glucose tests. The need for potential adjustment to the dosage of blood sugar-lowering medications may arise when used concurrently.


Q: How does Aceplus affect blood sugar levels?

The Paracetamol component is noted in regulatory information to potentially cause false results with certain types of blood glucose tests. The Aceclofenac component may also introduce the need for adjustment to blood sugar-lowering medications.


Q: Does Aceplus interact with common pain relievers like ibuprofen?

According to official product information, NSAIDs like ibuprofen may interact with both components of Aceplus. For the NSAID component, concurrent use of other NSAIDs is subject to caution, as it carries an increased risk of side effects.


Q: Does Aceplus have any known interactions with caffeine?

If the formulation contains caffeine (e.g., Paracetamol/Caffeine), official documents describe the caffeine as an active component that works to increase the analgesic effect and pain threshold.


Q: What happens if I drink alcohol while taking Aceplus?

Official warnings state that alcohol consumption is subject to caution. It can increase the risk for dangerously low blood pressure and may increase the chance of liver damage, especially when consuming large amounts regularly with the Paracetamol component.


Q: Are there any foods I should specifically avoid when using Aceplus?

Official instructions indicate the medicine should be taken one hour before a meal (on an empty stomach), as the Captopril component's absorption is significantly reduced by food.


Q: Can I use Aceplus if I am scheduled for surgery soon?

Official documents advise informing the doctor or dentist about Captopril/HCTZ use when scheduled for surgery. The Aceclofenac component is also contraindicated (not allowed) for perioperative pain management in certain bypass surgeries.


Q: Is Aceplus available in different forms, like a tablet, capsule, or liquid?

Regulatory documents describe the drug as a fixed-dose combination tablet. Official information does not typically list other liquid or capsule formulations for these specific combinations.


Q: Is Aceplus a type of steroid?

Official documentation describes the Aceclofenac component as an NSAID, which stands for Non-Steroidal Anti-Inflammatory Drug. This classification means it is not a steroid.


Q: Is Aceplus addictive or habit-forming?

Official references for some Aceplus components describe them as not habit-forming. The components in the combination products are not classified as controlled substances.


Q: How long does the primary effect of one dose of Aceplus last?

This dosing schedule of once daily indicates that the therapeutic effects are generally measured over a period of up to 24 hours.


Q: Does Aceplus require any special monitoring or blood tests while using it?

Official documents indicate that blood and urine tests may be necessary to check for unwanted effects, especially during long-term use. Monitoring of kidney function, liver function, and blood component levels may be recommended at regular intervals.


Q: Is a follow-up appointment needed after starting Aceplus?

Official instructions indicate that dose adjustments are typically considered only after six to eight weeks to fully assess the drug's efficacy. Regulatory product information advises that the patient's progress is assessed at regular visits to confirm the medicine is working properly.


Q: How is the safety profile of Aceplus generally described in official documents?

The overall safety information is presented in regulatory documents through the contraindications, side effects, and warning sections. These detail risks such as potential fetal harm (Captopril), risk of GI bleeding (Aceclofenac), and the need for regular patient monitoring.

How should Aceplus be stored and disposed of?

How to Store and Dispose of Aceplus?

Aceplus (Captopril/Hydrochlorothiazide) must be stored and handled according to regulatory conditions to ensure its quality and safety.


Storage Requirements

The medicine must be stored at Controlled Room Temperature, typically 20 C to 25 C, and protected from moisture and direct light. It is essential to keep the tablets in the original container, tightly closed, and out of the sight and reach of children and pets. The product must not be stored in the bathroom or any area prone to excess heat, and it must not be frozen. Do not use the medication past its expiration date.


Disposal Instructions

Unused or expired medication should be disposed of using an official drug take-back program. If a program is unavailable, secure the product for household trash by mixing it with an undesirable substance (like dirt or coffee grounds) and sealing it in a bag. Do not flush the medication down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aceplus found in:

A-Z Index: